Skip to content
Toggle main navigation
TEPHIConnect logo
TEPHIConnect logo
  • Home
  • About
    • About TEPHINET
    • About TEPHIConnect
    • Terms of Use and Privacy
  • How to Join
  • Why Join?
  • News
  • Events
  • Groups
  • Journals
    • BMC Medicine
    • BMC Medical Research Methodology
    • Clinical Epidemiology and Global Health
    • Emerging Microbes & Infections
    • Frontiers in Epidemiology
    • Global Health Journal
    • International Journal of Epidemiology
    • Online Library Journal
    • PLoS One
    • Science Direct Journal (Global Health)
    • Science Direct Journal (Clinical Epidemiology and Global Health)
    Log in
    Request to join

    News

    All
    abstract
    access to care
    acute febrile Illness
    adolescents
    adults
    afenet
    afghanistan
    africa
    african american
    alaskapox
    alumni spotlight
    amazon
    americas
    analysis
    antarctica
    See all

    Results (1)

    Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trial

    Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trial

    BackgroundDry eye disease has a high prevalence and exerts a significant negative effect on quality of life. In China, there are currently no available nasal sprays to promote natural tear production in patients with dry eye disease. We therefore evaluated the efficacy and safety of OC-01 (varenicline solution) nasal spray versus vehicle in Chinese patients with dry eye disease.MethodsThis was a r
    March 4, 2024
    Contact
    TEPHINET Secretariat

    330 W Ponce de Leon Ave

    Decatur

    GA 30030

    USA

    tephinet@taskforce.org
    +1-404-371-0466
    Links
    • Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET)
    • Privacy Policy
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.